Merck, Samsung to Develop and Manufacture Diabetes Drug

The companies collaborate to develop, commercialize MK-1293, an insulin glargine candidate for the treatment of type 1 and type 2 diabetes

Source: PharmaManufacturing.com - February 11, 2014 Category: Pharmaceuticals Source Type: news